Literature DB >> 18186495

Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?

Anamaria R Yeung1, Stanley L Liauw, Robert J Amdur, Anthony A Mancuso, Russell W Hinerman, Christopher G Morris, Douglas B Villaret, John W Werning, William M Mendenhall.   

Abstract

BACKGROUND: The purpose was to determine if postradiotherapy (RT) neck dissection can be limited to the neck levels of residual adenopathy on post-RT computed tomography (CT).
METHODS: In all, 274 patients with lymph node-positive head and neck squamous cell carcinoma were treated with definitive RT. All patients had a contrast-enhanced CT performed 4 weeks after completing RT to evaluate tumor response. Two hundred eleven heminecks were dissected, either planned pre-RT or because of residual adenopathy on post-RT CT. CT images were reviewed to determine the presence and location of residual adenopathy. Radiographic complete response (rCR) was defined as lymph node size < or =1.5 cm and normal radiographic morphology (no filling defects or calcifications). For each neck level the CT findings were correlated with neck dissection pathology.
RESULTS: Correlation of CT nodal response with neck dissection pathology revealed the following negative predictive values of rCR: level I, 100%; level II, 95%; level III, 98%; level IV, 96%; and level V, 96%. A subset analysis was performed on 61 neck levels with initially positive lymph nodes that completely responded to RT that were in a hemineck with residual lymphadenopathy elsewhere in the neck. Correlation of nodal response on CT to pathology indicated a negative predictive value of an rCR of 95% for this high-risk scenario. In 71 heminecks that underwent a selective neck dissection (defined as dissection of less than levels I-V) the 5-year neck control rate was 100%.
CONCLUSIONS: rCR on post-RT CT has a negative predictive value of > or =95% for each neck level. This suggests that limiting neck dissection based on post-RT CT is safe.

Entities:  

Mesh:

Year:  2008        PMID: 18186495     DOI: 10.1002/cncr.23279

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome.

Authors:  Ian Ganly; Jennifer Bocker; Diane L Carlson; Salvatore D'Arpa; Maria Coleman; Nancy Lee; David G Pfister; Jatin P Shah; Snehal G Patel
Journal:  Head Neck       Date:  2010-11-04       Impact factor: 3.147

2.  Primary radiotherapy for squamous cell carcinoma of the pyriform sinus.

Authors:  William M Mendenhall; Robert J Amdur; Christopher G Morris; Jessica Kirwan; Peter T Dziegielewski; John W Werning
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-14       Impact factor: 2.503

3.  Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.

Authors:  Chad Tang; Clifton D Fuller; Adam S Garden; Musaddiq J Awan; Rivka R Colen; William H Morrison; Steven J Frank; Beth M Beadle; Jack Phan; Erich M Sturgis; Mark E Zafereo; Randal S Weber; David I Rosenthal; G Brandon Gunn
Journal:  Oral Oncol       Date:  2014-11-28       Impact factor: 5.337

4.  Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making.

Authors:  Alfredo Páez-Carpio; Santiago Medrano-Martorell; Joan Berenguer; Africa Muxí; Isabel Vilaseca; Izaskun Valduvieco; Paola Castillo; Neus Baste; F Xavier Avilés-Jurado; Juan José Grau; Laura Oleaga
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-01       Impact factor: 3.236

5.  Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria.

Authors:  J D Hamilton; S Ahmed; V C Sandulache; S P Daram; T J Ow; H D Skinner; A Rao; L E Ginsberg; A J Kumar; J N Myers
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-07       Impact factor: 3.825

6.  Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.

Authors:  William R Kennedy; Michael P Herman; Rohan L Deraniyagala; Robert J Amdur; John W Werning; Peter T Dziegielewski; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-30       Impact factor: 2.503

7.  Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer.

Authors:  Mario López Rodríguez; Laura Cerezo Padellano; Margarita Martín Martín; Felipe Couñago Lorenzo
Journal:  Clin Transl Oncol       Date:  2008-12       Impact factor: 3.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.